Collegium Pharmaceutical News

Collegium Pharmaceutical Analyst Ratings

BenzingaJun 7 12:56 ET

Jefferies Upgrades Collegium to Buy, Cites Upside Related to LOEs

Seeking AlphaJun 7 12:14 ET

Collegium Downgraded by Piper Sandler Over Valuation

Seeking AlphaMay 10 13:14 ET

Collegium Pharmaceutical Analyst Ratings

BenzingaMay 10 05:27 ET

Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS), Collegium Pharmaceutical (COLL) and Intellia Therapeutics (NTLA)

TipRanksMay 10 05:15 ET

Collegium Pharmaceutical Analyst Ratings

BenzingaApr 11 05:58 ET

Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating

MT NewswiresFeb 26 11:29 ET

Truist Financial Sticks to Its Buy Rating for Collegium Pharmaceutical (COLL)

TipRanksFeb 26 07:16 ET

Collegium Pharmaceutical Analyst Ratings

BenzingaFeb 23 13:42 ET

Analysts Are Bullish on Top Healthcare Stocks: Collegium Pharmaceutical (COLL), Penumbra (PEN)

TipRanksFeb 23 07:31 ET

H.C. Wainwright Sticks to Their Hold Rating for Collegium Pharmaceutical (COLL)

TipRanksFeb 23 06:26 ET

Collegium Pharmaceutical Analyst Ratings

BenzingaFeb 2 06:55 ET

Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL) and Hologic (HOLX)

TipRanksFeb 2 06:00 ET

Analysts Are Bullish on Top Healthcare Stocks: Collegium Pharmaceutical (COLL), Spruce Biosciences (SPRB)

TipRanksJan 4 12:10 ET

Jefferies Downgrades Collegium Pharmaceutical to Hold, Raises Price Target to $37

BenzingaJan 4 08:09 ET

Collegium Pharmaceutical Analyst Ratings

BenzingaJan 4 08:07 ET

Analysts Conflicted on These Healthcare Names: Evotec AG (EVO), Collegium Pharmaceutical (COLL) and Fortrea Holdings Inc. (FTRE)

TipRanksJan 4 04:40 ET

Collegium Pharmaceutical (COLL) Gets a Buy From Truist Financial

TipRanksNov 8, 2023 21:29 ET

Collegium Pharmaceutical Analyst Ratings

BenzingaAug 25, 2023 02:58 ET

Collegium Pharmaceutical Analyst Ratings

BenzingaAug 4, 2023 12:47 ET